Crifos® (Fosfomycin Sodium) Fosfomycin sodium 4 g injection by Cipla. Genuine stock supplied in bulk/wholesale quantities to hospitals and pharmacies across India by A.K. Pharma, a licensed pharmaceutical distributor in Delhi.
| Composition | Fosfomycin sodium 4 g |
|---|---|
| Manufacturer | Cipla |
| Country | India |
| Pack size | Fosfomycin sodium 4 g: 1 vial / carton |
| Storage | Store as per carton and leaflet; original sealed pack |
Supplied only against a valid prescription from a registered medical practitioner.
Sourced from authorised channels
Temperature-controlled packing
Hospitals, clinics, pharmacies
Delhi drug licence holder
Crifos® (Fosfomycin Sodium) Fosfomycin sodium 4 g Injection — Intravenous Fosfomycin for Injection: A Sourcing Guide for Hospitals and Pharmacies
Crifos® is a brand of fosfomycin sodium for injection 4 g, marketed by Cipla. Intravenous fosfomycin is not marketed in the United States, so no US prescribing information exists for it; the US label for fosfomycin tromethamine describes a different, oral product. The approved indications of Crifos in India are defined by its pack insert and the Indian regulator. The decision to prescribe fosfomycin sodium, including patient selection, dose and monitoring, rests entirely with the treating physician. This page provides sourcing and procurement information for hospitals and pharmacies, not clinical or treatment guidance.
As both a trusted medicine distributor in Delhi and a licensed pharmaceutical distributor in Delhi, A.K. Pharma supplies genuine Crifos® (fosfomycin sodium) Fosfomycin sodium 4 g injection to hospitals and pharmacies across India. Buyers comparing pharmaceutical distribution companies and wholesale pharmaceutical distributors can also browse our full product range and the anti-biotic medicines category. Supply is in bulk/wholesale quantities only.
Crifos contains fosfomycin sodium 4 g as a powder for solution for intravenous infusion, supplied as one vial per carton, administered under medical supervision.
How it works, according to the label: Published reviews describe fosfomycin as a phosphonic acid antibacterial that inhibits an early step of bacterial cell wall synthesis, with a mechanism distinct from other antibiotic classes.
The current US prescribing information for the Crifos pack insert approved in India (no US intravenous fosfomycin label exists) (DailyMed) lists the following. Indications in India may differ and are defined by the Indian regulator and the Crifos pack insert.
No trial specific to this product is cited on this page. A comprehensive review of fosfomycin pharmacology and clinical use was published by Falagas et al. in Clinical Microbiology Reviews in 2016. Evidence is cited for information only and is not a recommendation for any patient; the approved pack insert governs.
| Strength | Dosage form | Pack size (as shown on the carton) |
|---|---|---|
| Fosfomycin sodium 4 g | Powder for solution for intravenous infusion | 1 vial / carton |
Please confirm the current pack and batch with us before ordering. Dose and regimen must be determined and followed exactly as directed by the treating physician and the approved prescribing information.
This page is written for hospital pharmacists, critical-care and infectious-disease department buyers, and pharmacies that source injectable antibiotics. Fosfomycin is prescribed and supervised by a physician, as described in the pack insert.
Published reviews of intravenous fosfomycin describe gastrointestinal effects, injection-site reactions and phlebitis, and changes in serum electrolytes (hypernatremia and hypokalemia) related to its sodium load. This list is not complete; the Crifos pack insert governs.
All use should follow the approved prescribing information and the instructions of the treating physician.
Please follow the storage instructions printed on the Crifos carton and leaflet, including time limits after reconstitution. Keep out of reach of children.
Crifos is marketed by Cipla. A.K. Pharma is a licensed distributor and does not manufacture the product. As one of the pharmaceutical distributors serving Indian hospitals, we source Crifos through authorised channels and supply it with pack and batch details. Buyers comparing a pharmaceutical wholesale distributors list or a pharma distribution company can verify our credentials on the About Us page.
Is Crifos available in India?
A.K. Pharma supplies Crifos (fosfomycin sodium) Fosfomycin sodium 4 g injection to hospitals and pharmacies in India. Contact us for current availability.
What does Crifos contain?
Fosfomycin sodium 4 g, an intravenous antibiotic supplied as a single-use powder vial.
Can I order a single pack?
A.K. Pharma is a distributor and supplies bulk/wholesale quantities only, not one or two pieces.
How should Crifos be stored?
Follow the carton and leaflet, including time limits after reconstitution.
Does A.K. Pharma advise on dosing or suitability?
No. Treatment decisions, including dosing, rest solely with the treating physician and the approved prescribing information.
How do I request a quote?
Call or WhatsApp us, or use the contact details below.
📍 E-2/257A, 2nd Floor, Shastri Nagar, New Delhi 110052
📞 011 4172 6999
📱 WhatsApp: +91 9810034827
🌐 akpharma.in
Disclaimer: This page is intended for informational and sourcing/procurement purposes only and does not constitute medical or clinical advice. A.K. Pharma is a licensed medicine distributor, not a healthcare provider, and does not provide clinical guidance. All treatment decisions, including drug selection and dosing, rest solely with the treating physician and should follow the approved prescribing information.
